Primary |
Rhinitis Allergic |
14.3% |
Hypersensitivity |
12.5% |
Pruritus |
12.5% |
Seasonal Allergy |
9.2% |
Hypertension |
7.6% |
Urticaria |
6.1% |
Dermatitis Atopic |
5.1% |
Multiple Allergies |
4.9% |
Rash |
3.5% |
Asthma |
3.1% |
Urticaria Chronic |
3.1% |
Diabetes Mellitus |
2.7% |
Food Allergy |
2.5% |
Eczema |
2.3% |
Insomnia |
2.0% |
Prophylaxis |
2.0% |
Rhinitis |
1.8% |
Erythema |
1.6% |
Nasopharyngitis |
1.6% |
Dermatitis |
1.4% |
|
Somnolence |
12.6% |
Urticaria |
8.6% |
Platelet Count Decreased |
7.3% |
Liver Function Test Abnormal |
6.0% |
Loss Of Consciousness |
6.0% |
Metrorrhagia |
6.0% |
Electrocardiogram Qt Prolonged |
5.3% |
Malaise |
5.3% |
Rash |
5.3% |
Maternal Exposure During Pregnancy |
4.0% |
Weight Decreased |
4.0% |
Anaphylactic Shock |
3.3% |
Aspartate Aminotransferase Increased |
3.3% |
Atrial Fibrillation |
3.3% |
Hepatic Function Abnormal |
3.3% |
Liver Disorder |
3.3% |
Pregnancy |
3.3% |
Pyrexia |
3.3% |
Renal Impairment |
3.3% |
Stevens-johnson Syndrome |
3.3% |
|
Secondary |
Product Used For Unknown Indication |
15.6% |
Drug Use For Unknown Indication |
12.8% |
Hypersensitivity |
8.6% |
Hypertension |
8.0% |
Pain |
6.1% |
Arthralgia |
5.7% |
Bone Pain |
5.6% |
Fatigue |
5.6% |
Seasonal Allergy |
4.3% |
Rhinitis |
4.0% |
Thrombosis Prophylaxis |
3.7% |
Pruritus |
2.9% |
Multiple Allergies |
2.6% |
Osteoarthritis |
2.6% |
Anxiety |
2.2% |
Erythrosis |
2.2% |
Urticaria |
2.2% |
Depression |
1.9% |
Anaemia |
1.8% |
Dermatitis Atopic |
1.8% |
|
Urticaria |
11.2% |
Somnolence |
7.9% |
Transaminases Increased |
7.9% |
Ventricular Extrasystoles |
7.9% |
Prothrombin Time Prolonged |
6.7% |
Thrombocytopenia |
6.7% |
Hepatitis |
5.6% |
Sudden Death |
5.6% |
Cytolytic Hepatitis |
4.5% |
Liver Function Test Abnormal |
4.5% |
Pregnancy |
4.5% |
Drug Eruption |
3.4% |
Drug Ineffective |
3.4% |
Hepatitis Cholestatic |
3.4% |
Oedema |
3.4% |
Postnasal Drip |
3.4% |
Wrong Drug Administered |
3.4% |
Altered State Of Consciousness |
2.2% |
Central Nervous System Abscess |
2.2% |
Developmental Delay |
2.2% |
|
Concomitant |
Product Used For Unknown Indication |
28.6% |
Drug Use For Unknown Indication |
13.5% |
Asthma |
9.4% |
Hepatitis C |
7.9% |
Prophylaxis |
5.3% |
Hypertension |
4.9% |
Hypersensitivity |
4.5% |
Chronic Hepatitis C |
4.1% |
Rheumatoid Arthritis |
3.2% |
Pain |
3.0% |
Gastrooesophageal Reflux Disease |
2.7% |
Depression |
2.1% |
Multiple Allergies |
1.8% |
Psoriasis |
1.5% |
Contraception |
1.3% |
Diabetes Mellitus |
1.3% |
Insomnia |
1.3% |
Pruritus |
1.3% |
Anxiety |
1.2% |
Osteoporosis |
1.2% |
|
Vomiting |
8.8% |
White Blood Cell Count Decreased |
8.2% |
Urticaria |
7.7% |
Thrombocytopenia |
7.3% |
Rash |
6.7% |
Sinusitis |
5.6% |
Weight Increased |
5.4% |
Weight Decreased |
5.2% |
Pulmonary Embolism |
4.3% |
Pyrexia |
4.3% |
Headache |
4.1% |
Nausea |
4.1% |
Anaemia |
3.9% |
Dyspnoea |
3.9% |
Drug Ineffective |
3.6% |
Pain |
3.6% |
Pruritus |
3.6% |
Drug Rash With Eosinophilia And Systemic Symptoms |
3.4% |
Neutrophil Count Decreased |
3.4% |
Drug Eruption |
3.0% |
|
Interacting |
Auricular Swelling |
33.3% |
Attention Deficit/hyperactivity Disorder |
16.7% |
Breast Cancer |
16.7% |
Rheumatoid Arthritis |
16.7% |
Rhinitis Allergic |
16.7% |
|
Irritability |
33.3% |
Somnolence |
33.3% |
Urticaria |
33.3% |
|